These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22224041)

  • 1. Drug-drug interactions in hospitalized cardiac patients.
    Mateti U; Rajakannan T; Nekkanti H; Rajesh V; Mallaysamy S; Ramachandran P
    J Young Pharm; 2011 Oct; 3(4):329-33. PubMed ID: 22224041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
    Fettah H; Moutaouakkil Y; Sefrioui MR; Moukafih B; Bousliman Y; Bennana A; Lamsaouri J; Makram S; Cherrah Y
    Pan Afr Med J; 2018; 29():225. PubMed ID: 30100979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on drug-drug interactions through prescription analysis in a South Indian teaching hospital.
    Kulkarni V; Bora SS; Sirisha S; Saji M; Sundaran S
    Ther Adv Drug Saf; 2013 Aug; 4(4):141-6. PubMed ID: 25114777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa.
    Fasipe OJ; Akhideno PE; Nwaiwu O; Adelosoye AA
    Clin Pharmacol; 2017; 9():125-132. PubMed ID: 29123429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Risk of Drug-drug interactions among Hospitalized Patients with kidney Diseases at a Nigerian Teaching Hospital: A Call for Action.
    Busari AA; Oreagba IA; Oshikoya KA; Kayode MO; Olayemi SO
    Niger Med J; 2019; 60(6):317-325. PubMed ID: 32180663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital.
    Sivva D; Mateti UV; Neerati VM; Thiruthopu NS; Martha S
    Avicenna J Med; 2015; 5(2):29-35. PubMed ID: 25878964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
    Moura C; Prado N; Acurcio F
    Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of drug-Drug interactions among the hypertensive patients in a tertiary care teaching hospital.
    Subramanian A; Adhimoolam M; Kannan S
    Perspect Clin Res; 2018; 9(1):9-14. PubMed ID: 29430412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation.
    Rodrigues J; Marques P; Gomes C; Portela C
    Cureus; 2023 Feb; 15(2):e35324. PubMed ID: 36994248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of drug-drug interactions in hospitalized patients on medications for OUD.
    Berger O; Rector K; Meredith J; Sebaaly J
    Ment Health Clin; 2021 Jul; 11(4):231-237. PubMed ID: 34316418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity and management of drug-drug interactions in acute geriatric patients.
    Lea M; Rognan SE; Koristovic R; Wyller TB; Molden E
    Drugs Aging; 2013 Sep; 30(9):721-7. PubMed ID: 23681400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
    Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
    Guastaldi RB; Reis AM; Figueras A; Secoli SR
    Int J Clin Pharm; 2011 Dec; 33(6):1002-9. PubMed ID: 21993569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and contributors to potential drug-drug interactions in hospitalized patients.
    Reimche L; Forster AJ; van Walraven C
    J Clin Pharmacol; 2011 Jul; 51(7):1043-50. PubMed ID: 20926752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interactions in neonatal intensive care: A prospective cohort study.
    Costa HT; Leopoldino RWD; da Costa TX; Oliveira AG; Martins RR
    Pediatr Neonatol; 2021 Mar; 62(2):151-157. PubMed ID: 33158761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of CYP3A4-related potential drug-drug interactions in outpatients receiving prescriptions from multiple clinical departments.
    Matsuoka R; Akagi S; Konishi T; Kondo M; Matsubara H; Yamamoto S; Izushi K; Tasaka Y
    J Pharm Health Care Sci; 2024 Aug; 10(1):48. PubMed ID: 39103904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.